| Filed On | Filing |
|---|---|
| 07 Aug 2026 |
Form 4: Maraldo David R., EVP & Pres. MMD · Merck & Co Inc
Received 18,706 shares by exercise or conversion ($1.54M) · Sold 18,706 shares ($2.41M) |
| 07 May 2026 |
Form 4: Maraldo David R., EVP & Pres. MMD · Merck & Co Inc
Granted 7,424 Restricted Stock Unit · Granted 21,731 Stock Option (Right to Buy) |
| 05 May 2026 |
Form 4: Maraldo David R., EVP & Pres. MMD · Merck & Co Inc
Received 552 shares by exercise or conversion ($61.9K) · Gave up 159 shares to cover exercise price or tax ($17.8K) |
Loading...
